Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gervais

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Annales Francaises D'Anesthesie Et De Reanimation|August 24, 2010
[Interest of evaluation of professional practice for the improvement of the management of postoperative pain with patient controlled analgesia (PCA)]A Baumann, E Cuignet-Royer, C Cornet, et al.
International Immunopharmacology|April 9, 2013
Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primatesMichael J McCluskie, David C Pryde, David P Gervais, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2023
[M A Peyronneau, B Kuhnast, D-L Nguyen, et al.
International Immunopharmacology|September 26, 2015
Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primatesMichael J McCluskie, Jennifer Thorn, David P Gervais, et al.
Plos One|October 8, 2013
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceDavid C Pryde, Lyn H Jones, David P Gervais, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Annales Francaises D'Anesthesie Et De Reanimation|August 24, 2010
[Interest of evaluation of professional practice for the improvement of the management of postoperative pain with patient controlled analgesia (PCA)]A Baumann, E Cuignet-Royer, C Cornet, et al.
International Immunopharmacology|April 9, 2013
Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primatesMichael J McCluskie, David C Pryde, David P Gervais, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2023
[M A Peyronneau, B Kuhnast, D-L Nguyen, et al.
International Immunopharmacology|September 26, 2015
Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primatesMichael J McCluskie, Jennifer Thorn, David P Gervais, et al.
Plos One|October 8, 2013
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in miceDavid C Pryde, Lyn H Jones, David P Gervais, et al.
Pageof 17